Cycloplegic Delivery Investigation

This study has been completed.
Sponsor:
Information provided by:
Ohio State University
ClinicalTrials.gov Identifier:
NCT00472524
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
  Purpose

The goal of this study is to compare the effectiveness of the administration of sequential drops, a combination drop and a combination spray for producing mydriasis and cycloplegia.


Condition Intervention
Healthy
Procedure: Mydriasis/cycloplegia via different modes of administration

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Further study details as provided by Ohio State University:

Estimated Enrollment: 50
  Eligibility

Ages Eligible for Study:   8 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients ages 8 to 30 with best corrected acuity of 20/30 or better in both eyes at distance and near will be recruited.

Exclusion Criteria:

  • vision not correctable to 20/30 or better
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00472524

Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472524     History of Changes
Other Study ID Numbers: 2003H0072
Study First Received: May 9, 2007
Last Updated: July 1, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on April 17, 2014